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Abstract
Background: Human Papillomavirus (HPV)-16 is a paradigm for ‘‘high-risk’’ HPVs, the causative agents of virtually all cervical
carcinomas. HPV E6 and E7 viral genes are usually expressed in these tumors, suggesting key roles for their gene products,
the E6 and E7 oncoproteins, in inducing malignant transformation.
Methodology/Principal Findings: By protein-protein interaction analysis, using mass spectrometry, we identified
glutathione S-transferase P1-1 (GSTP1) as a novel cellular partner of the HPV-16 E7 oncoprotein. Following mapping of
the region in the HPV-16 E7 sequence that is involved in the interaction, we generated a three-dimensional molecular
model of the complex between HPV-16 E7 and GSTP1, and used this to engineer a mutant molecule of HPV-16 E7 with
strongly reduced affinity for GSTP1.When expressed in HaCaT human keratinocytes, HPV-16 E7 modified the equilibrium
between the oxidized and reduced forms of GSTP1, thereby inhibiting JNK phosphorylation and its ability to induce
apoptosis. Using GSTP1-deficient MCF-7 cancer cells and siRNA interference targeting GSTP1 in HaCaT keratinocytes
expressing either wild-type or mutant HPV-16 E7, we uncovered a pivotal role for GSTP1 in the pro-survival program elicited
by its binding with HPV-16 E7.
Conclusions/Significance: This study provides further evidence of the transforming abilities of this oncoprotein, setting the
groundwork for devising unique molecular tools that can both interfere with the interaction between HPV-16 E7 and GSTP1
and minimize the survival of HPV-16 E7-expressing cancer cells.
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Introduction
Human Papillomaviruses (HPVs) are small DNA viruses with a
marked propensity for infecting epithelial tissues. The numerous
HPV genotypes are subdivided into ‘‘low-risk’’ HPVs, which cause
benign neo-formations, and ‘‘high-risk’’ HPVs, which cause lesions
with a predisposition to carcinogenic transformation. High-risk
HPVs are associated with ano-genital carcinomas (principally
cancers of the uterine cervix) [1,2], oropharyngeal squamous cell
carcinomas [3], and cutaneous malignancies (non-melanoma skin
cancers) [4]. In particular, HPV-16 and HPV-18 are the causative
agents of at least 90% of cervical cancers and are linked to more
than 50% of other ano-genital cancers. In a vast majority of these
tumors, which are usually diagnosed several years after HPV
infection, a physical integration of the viral genome into cancer
cell chromosomes is observed. Such integration often partially
disrupts the HPV genome, but the E6 and E7 viral genes are
usually retained and constitutively expressed by the host cell. This
suggests key roles for their respective gene products, the E6 and E7
oncoproteins, in inducing malignant transformation [2,5,6]. These
viral proteins act as multifaceted devices that re-program host cell
functions at multiple levels, weakening the normally tight links
between cellular differentiation and proliferation. In spite of being
only 98 amino acids in length, the E7 protein of HPV-16 contains
many features that have evolved to assist viral replication in the
host cell. The expression of these oncoproteins favors the rise of
and selection for clones with a high frequency of transformation.
The most well understood and probably crucial role of HPV-16
E7 is its ability to neutralize the function of the RB family of tumor
and growth suppressor proteins. In addition, several other HPV-16
E7 functions that can act synergistically to favor HPV replication
in host cells have been described [7–9].
The central role of HPV-16 E7 in human oncogenesis
prompted us to search for novel cellular targets of this viral
oncoprotein. We screened for the host cell proteins that interact
with recombinant HPV-16 E7 (UniProtKB/Swiss-Prot accession
number P03129) by fishing with a tagged HPV-16 E7 construct,
with subsequent identification by mass spectrometry. Using this
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UniProtKB/Swiss-Prot accession number P09211) as the preem-
inent cellular partner of HPV-16 E7. Glutathione S-transferases
(GST) are a family of homodimeric enzymes that play a pivotal
role in cell detoxification by catalyzing the conjugation of many
endogenous and exogenous hydrophobic electrophiles (such as
xenobiotics) with reduced glutathione, thus neutralizing their
effects within the cellular environment [10]. Remarkably, GSTP1
also possesses a regulatory function: in form of reduced monomer,
it interacts with the C-terminus of c-Jun N-terminal kinase (JNK)
and negatively regulates the ability of JNK to phosphorylate the
Jun protein. In this way, JNK-mediated signal transduction, which
can lead to apoptosis, is down-regulated [11,12]. For these
reasons, GSTP1 appears to be crucial for cell survival and
inhibition of apoptosis, and is considered to be important for the
survival of transformed clones and for cancer drug resistance [13].
Indeed, GSTP1 expression levels and/or polymorphisms increase
in parallel with neoplastic progression and are negative prognostic
factors in several human tumors [14–16].
In the present study, we show that HPV-16 E7 expression in
immortalized human keratinocytes alters the cellular redox
equilibrium and induces cell survival by stabilizing a subset of
the GSTP1 protein in its reduced monomeric form.
Results
HPV-16 E7 physically interacts with GSTP1
To identify novel cellular partners of the E7 protein from ‘‘high-
risk’’ HPVs, recombinant E7 from HPV strain 16 was N-terminally
tagged with the S. japonicum GST (S.j GST) and incubated in cell
lysates from HaCaT immortalized human keratinocytes [17].
Proteins that were entrapped using immobilized glutathione as
selective bait for the recombinant S.j GST-HPV16 E7 were resolved
by SDS-PAGE. A number of specific bands were identified in
samples incubated with S.j GST-HPV-16 E7 but not with S.j GST
alone. Among these bands, a protein with an apparent molecular
mass of approximately 23–25 kDa was prominent (Figure 1A, dotted
arrow). This band was excised, proteolyzed by trypsin and identified
by peptide mass fingerprinting as human glutathione S-transferase
P1-1 (GSTP1). In this context, no other bands were analyzed.
Because HaCaT GSTP1 might interact per se with immobilized
glutathione, it was necessary to validate this interaction using
alternative experimental procedures. To this end, we generated a
recombinant protein with a His tag added to the N-terminus (N-
6His tag) of human GSTP1 which enables binding to immobilized
nickel (Ni-NTA-agarose). This protein was incubated with
radiolabeled in vitro translated (IVT) HPV-16 E7. Our result
showed that recombinant GSTP1 indeed interacted specifically
with IVT HPV-16 E7, whereas recombinant regulator of
chromosome condensation 1 (RCC1) [18], which was used as an
irrelevant 6-His fusion protein control, did not (Figure 1B).
To investigate the ability of HPV-16 E7 to interact with GSTP1
in vivo, we transfected the Phoenix cell line [19] with pcDNA3T7
Tag (control) or pcDNA3T7 Tag HPV-16 E7 plasmids. After
immunoprecipitation using an anti-T7 antibody, Western blot
analysis detected co-precipitated GSTP1 only in HPV-16 E7-
expressing cells (Figure 1C).
Subsequently, we expressed HPV-16 E7 in HaCaT keratino-
cytes via the pLXSN retroviral vector (see Materials and
Methods). HA-tagged HPV-16 E7 protein expression was
confirmed by Western blotting. In parallel, a cell clone bearing
the empty retroviral vector (control) was also produced (Figure S1).
After immunoprecipitation using an anti-HPV-16 E7 antibody,
Western blot analysis revealed the co-precipitation of GSTP1 only
in HPV-16 E7-expressing cells (Figure 1D). Alternatively, in the
same cells, following immunoprecipitation using an anti-GSTP1
antibody, the presence of co-precipitated HPV-16 E7 was
detectable by Western blot (using an anti-HA antibody) only in
HPV-16 E7-expressing cells (Figure 1E). In addition, using an anti-
HPV-16 E7 antibody we immunoprecipitated HPV-16 E7 in the
CaSki [20] and SiHa [21] cervical carcinoma cell lines, known to
express HPV-16 E7 endogenously [22,23], GSTP1 also co-
precipitated with the viral oncoprotein in these cells, as detected
by Western blot analysis (Figure 1F).
In order to assess whether GSTP1 was able to interact with E7
oncoproteins from ‘‘high-risk’’ HPVs other than HPV-16, we
challenged recombinant N-6His-GSTP1 with radiolabeled IVT
HPV-33 and HPV-18 E7 molecules, which interacted in vitro
specifically with recombinant GSTP1, but not with recombinant
RCC1, which was used as a control (Figure 1G).
Identification of the amino acid sequences mediating the
interaction between HPV-16 E7 and GSTP1
To identify the regions of the HPV-16 E7 molecule involved in
its interaction with GSTP1, we took advantage of the PepSets
TM
technique (see Materials and Methods). A set of oligopeptides was
synthesized on polypropylene rods as 12-mers with a 9 amino acid
overlap, to cover the entire length of HPV-16 E7 (98 amino acids).
Rod-bound peptides were then assayed for their ability to bind to
recombinant GSTP1 with immunoenzymatic measurements of the
amount of GSTP1 captured by each rod. The results of these
experiments identified the central (aa 49–60) and C-terminal
portions (aa 89–98) of HPV-16 E7 as the most important regions
for its binding to GSTP1 (Figure 2). Interestingly, these two
regions fall within the CR3 zinc finger domain.
Docking of HPV-16 E7 to GSTP1
Docking of the modeled CR3 domain of HPV-16 E7 onto a
GSTP1 monomer was accomplished with the Hex program,
including calculations of both shape complementarity and electro-
static contributions. The best HPV-16 E7 CR3/GSTP1 interaction
model is shown in Figure 3A. Interestingly, the strongly interacting
peptide49–60 (see Figure 2) corresponds to a portion ofHPV-16E7
that dwells nicely in a groove in the GSTP1 protein in our modeled
complex (see belowFigure4A).Thisintermolecularinteraction does
notappearto be mediated bydisulfide formationinvolvingcysteines
from the oligopeptide and GSTP1. The docking also suggests that
the interaction with HPV-16 E7 involves the same GSTP1 surface
region that participates in homodimerization with a second GSTP1
molecule, as seen in the native enzyme homodimer in the Protein
Data Bank (PDB) structure 1AQW (Figures 3B and 3C). It was also
observed that HPV-16 E7 binding does not impose any apparent
steric hindrance on the residues forming the active site of the
enzyme, the glutathione binding site (G-site, occupied by a
glutathione molecule in Figure 3A), or the substrate binding site
(H-site, occupied by chlorambucil in Figure 3A). In fact, the
addition of excess reduced glutathione (GSH) (up to a 10-fold molar
ratio between GSH and GSTP1) did not modify the amount of
GSTP1 bound to the HPV-16 E7-derived oligopeptides (data not
shown). Furthermore, GSTP1 interacts directly with only one of the
twosubunitsoftheHPV-16E7dimer,leavingtheothersubunit free
to potentially interact with another GSTP1 monomer.
Generation of a HPV-16 E7 mutant with impaired ability
to bind to GSTP1
Based on the docking model shown in Figure 3, we engineered
the HPV-16 E7 sequence to obtain a mutant protein carrying
E7 and GSTP1 in Cell Survival
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interface of the interaction between E7 and GSTP1. In particular,
the mutant, named HPV-16 E7 Mut, was substituted at Val 55,
Phe 57, and Met 84 (Figure 4A), based on the following
considerations: 1) these three amino acids are poorly conserved
in E7 proteins across the various Papillomavirus types; 2) and
according to our CR3 domain model, they do not appear to
contribute to the stabilization of the HPV-16 E7 dimer; and 3)
their side chains form the largest hydrophobic and solvent-exposed
region on the surface of the CR3 dimer, suggesting that this group
of residues might contribute at least in part to the interaction
between HPV-16 E7 and other proteins. Interestingly, we also
noticed that three hydrophobic amino acids are also present in
other of the most aggressive HPV strains (18, 31, 33, 45 and 59) at
positions corresponding to the residues Val 55, Phe 57 and Met 84
of HPV-16 E7, while the hydrophobic character of the same
amino acid sites is poorly conserved across all HPV strains.
Figure 4A shows how the two strong interacting peptides found by
means of the PepSets
TM technique are positioned in the structure
of the docked HPV-16 E7-GSTP1 complex. Although, in the
model, the interaction of HPV-16 E7 with GSTP1 appears to
involve the 49–60 12-mer predominantly, with little contribution
Figure 1. HPV-16 E7 physically interacts with GSTP1. A: HaCaT cell lysate was incubated with the S. japonicum GST-HPV-16 E7 chimeric protein.
Co-precipitated proteins were separated by SDS-PAGE and visualized after silver staining. The dotted arrow indicates the band that was cut out and
identified by peptide mass fingerprinting as human GSTP1. B: In vitro interaction of radiolabeled IVT HPV-16 E7 with N-6His-GSTP1 recombinant
protein and lack of interaction with control N-6His-RCC1 recombinant protein. C: Western blot for GSTP1 after immunoprecipitation with an anti-T7
Tag antibody (to precipitate tagged HPV-16 E7), in control and HPV-16 E7-transfected Phoenix cells shows co-precipitation of GSTP1 only in HPV-16
E7-expressing cells. D: Western blot for GSTP1 after immunoprecipitation with an anti-HPV-16 E7 antibody in control and HPV-16 E7-expressing
HaCaT cells shows co-precipitation of GSTP1 only in HPV-16 E7-expressing cells. E: Western blot using an anti-HA antibody (to detect tagged HPV-16
E7) after immunoprecipitation with an anti-GSTP1 antibody in control and HPV-16 E7-expressing HaCaT cells shows co-precipitation of HPV-16 E7. F:
Western blot for GSTP1 after immunoprecipitation with an anti-HPV-16 E7 antibody in control and HPV-16 E7-expressing HaCaT cells as well as in the
CaSki and SiHa cell lines expressing endogenous HPV-16 E7. G: In vitro interaction of radiolabeled IVT HPV-33 E7 and HPV-18 E7 with N-6His-GSTP1
recombinant protein and lack of interaction with control N-6His-RCC1 recombinant protein.
doi:10.1371/journal.pone.0007254.g001
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interaction observed for the corresponding peptides with the
PepSets
TM technique could be attributed to conformational
differences. In particular, the interaction of the C-terminal peptide
with GSTP1 might be enhanced when this peptide is in the form
of a structurally less-restrained 12-mer, as opposed to when it is
embedded into the folded CR3 domain.
Radiolabeled IVT HPV-16 E7 and HPV-16 E7 Mut were
incubated with recombinant GSTP1. Subsequent SDS-PAGE and
autoradiography experiments showed that, in vitro, using recom-
binant proteins, only the wild-type HPV-16 E7 molecule
interacted with GSTP1; recombinant RCC1 was used as a
negative control (Figure 4B). In addition, the molecular perturba-
tions induced in HPV-16 E7 Mut did not interfere with the ability
of the oncoprotein to bind in vitro to the oncosuppressor protein
pRb, a molecular target of E7 (Figure 4C).
HaCaT cells were subsequently engineered to express the HPV-
16 E7 Mut molecule (Figure S1), in order to evaluate its effects in
various biological assays when compared to the wild-type
molecule. Either wild-type or mutant HPV-16 E7 was expressed
as HA-tagged proteins. To assay the ability of HPV-16 E7 Mut to
interact with GSTP1 in vivo, control, HPV-16 E7-infected and
HPV-16 E7 Mut-infected HaCaT cells were lysed and immuno-
precipitation using an anti-HA antibody was performed. Subse-
quently, the amount of co-precipitated GSTP1 was determined by
Western blotting. The efficiency of the immunoprecipitation
procedure was assessed by probing the same membrane with an
anti-HA antibody (Figure 4D). Reverse co-immunoprecipitation
was also carried out, by immunoprecipitating the same lysates with
an anti-GSTP1 antibody and determining by means of Western
blotting the amount of HPV-16 E7 and HPV-16 E7 Mut
coprecipitated, using an anti-HA antibody. The efficiency of the
immunoprecipitation procedure was assessed by probing the same
membrane with an anti-GSTP1-antibody (Figure 4E). Both in vivo
experiments confirmed the interaction between HPV-16 E7 and
GSTP1, and also showed that the ability of HPV-16 E7 Mut to
interact with GSTP1 was drastically reduced, but not abolished.
GSTP1 activities in HPV-16 E7-expressing and HPV-16 E7
Mut-expressing HaCaT cells
To explore the in vivo role of HPV-16 E7 in epithelial cells, we
investigated the effects of HPV-16 E7 and HPV-16 E7 Mut
expression on GSTP1 total protein content and assayed its known
functions in our HaCaT model system.
Western blot analysis for GSTP1 showed comparable amounts
of protein in control cells and HPV-16 E7- and HPV-16 E7 Mut-
expressing HaCaT cells (Figure 5A). RNA extracted from these
cells was assayed for GSTP1 transcript levels by real-time
quantitative PCR, showing only insignificant differences among
the cells (data not shown). GSTP1 catalytic activity was not
significantly affected in HPV-16 E7 and HPV-16 E7 Mut-
expressing cells, with respect to the control samples (Figure 5B),
suggesting that enzymatic GSTP1 activity was not altered by the
binding with its viral oncoprotein.
Besides its enzymatic activity, the pro-survival properties of
GSTP1 via the JNK cascade should be considered. In fact, GSTP1,
in form of reduced monomer, enhances cell survival by inhibiting
JNK phosphorylation and its signaling cascade activity; phosphor-
ylated (activated) JNKcan phosphorylate Jun, a member of the AP1
transcriptional regulator, thus eliciting a JNK-dependent apoptotic
cascade [11,12]. Therefore, we assayed JNK phosphorylation levels
in control cells and in HPV-16 E7- or HPV-16 E7 Mut-expressing
HaCaT cells, untreated or after UV irradiation. In non-irradiated
cells (untreated), no evident changes in pJNK expression were
found; on the other hand, after UV irradiation, cells expressing
HPV-16 E7 displayed markedly reduced JNK phosphorylation
when compared to the related control, while the reduction was less
evident in cells expressing HPV-16 E7 Mut. In contrast, total
intracellular JNK levels appeared essentially unaffected (Figure 5C).
HPV-16 E7 influence on the balance between oxidized
and reduced GSTP1
The GST proteins are known to undergo polymerization via
interchain disulfide bridges in an oxidizing environment To assay
Figure 2. Identification of HPV-16 E7 peptide sequences involved in the interaction with GSTP1. The entire HPV-16 E7 amino acid
sequence, reproduced as 12-mers with a 9 amino acid overlap, was synthesized on 30 different polypropylene rods. The histogram represents the
ability of each 12-mer oligopeptide to bind recombinant GSTP1. The histogram corresponding to the 30
th rod refers to amino acids 88–99 because a
Gly has been added to the last C-terminal HPV-16 E7 amino acid in order to complete the 12-mer. Values are averages of three different
experiments6SD.
doi:10.1371/journal.pone.0007254.g002
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control and HPV-16 E7-infected HaCaT cells were assayed by
Western blot for GSTP1 protein levels after non-reducing SDS-
PAGE [24,25]. Under basal (untreated) conditions, this assay
revealed a decrease in the amount of multimeric oxidized GSTP1
in HPV-16 E7-expressing cells compared to that in control cells.
This effect was even more evident after the induction of oxidative
stress by UV irradiation or exposure to H2O2, which caused a
substantial increase in the oxidized forms of the enzyme in control
cells. In all cases, HPV-16 E7-expressing cells displayed a marked
decrease not only in the multimeric oxidized form, but also in the
monomeric oxidized form of GSTP1 (Figure 6A). This monomeric
oxidized form is generated by an intrasubunit disulfide bond
between the Cys-47 and Cys-101 residues [24,25] and is
distinguishable from the reduced form because of its higher
electrophoretic mobility. By assaying the effect of HPV-16 E7 Mut
expression on the equilibria between multimeric and monomeric,
and oxidized or reduced GSTP1 in UV-irradiated HaCaT cells,
we found that the mutant oncoprotein appeared less proficient
than the wild-type in protecting GSTP1 from oxidation
(Figure 6B). This result could be interpreted in light of the
partially impaired binding of the mutant oncoprotein to the
GSTP1 molecule. The residual binding ability could be also
attributable to the C-terminal region of the HPV-16 E7 (see
Figure 2).
HPV-16 E7 expression and redox equilibrium
We assayed a set of biochemical parameters to estimate the
possible interference from either wild-type or mutant HPV-16 E7
with the cellular redox equilibrium. We determined in control and
HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT cells: a) the
amount of thiobarbituric acid reactive substances (TBARS), which
are the degradation end-products of peroxidated lipids; b) the
content of polyunsaturated fatty acids (PUFAs), which are the first
targets of lipoperoxidative insult; c) the enzyme activity levels of
superoxide dismutase (SOD), catalase, and glutathione peroxidase
(GSH-Px); and d) the amount of GSH, which is the most
important free radical scavenger. The results, shown in Table 1,
indicate significant differences between control and HPV-16 E7-
expressing cells, with respect to parameters related to lipid
peroxidation (TBARS and PUFA), cytosolic redox equilibrium
(SOD, catalase, and GSH-Px) and GSH content, all of which are
consistent with the hypothesis that HPV-16 E7 induces oxidative
stress. In cells expressing HPV-16 E7 Mut, significant differences
with the control were found in the SOD, catalase, and GSH-Px
activities, as well as in the total GSH content, while significant
differences with HPV-16 E7-expressing cells were only observed in
regards to TBARS and GSH-Px. In summary, expression of either
HPV-16 E7 or HPV-16 E7 Mut appears to be linked to the
condition of marked cellular stress.
Role of GSTP1 and HPV-16 E7 in cell survival after UV
exposure
To assay the role of GSTP1 and HPV-16 E7 in cell survival
after UV exposure, we used two cellular models: 1) the HaCaT
cells and 2) the MCF-7 human breast carcinoma cell line [26].
The latter lacks GSTP1 expression [27] because of promoter
hypermethylation [28]. As for HaCaT keratinocytes, we expressed
HPV-16 E7 in MCF-7 cells via the pLXSN vector. A control clone
was produced in parallel. HPV-16 E7 expression in both cell lines
was confirmed by Western blotting. As expected, GSTP1
expression was undetectable in both control and HPV-16 E7-
expressing MCF-7 cells (Figure S2A).
To estimate the specific role of GSTP1, we forced its expression
in control and HPV-16 E7-infected MCF-7 cells by electropora-
tion (MCF-7+GSTP1 cells) (Figure S2B). Aliquots of control and
HPV-16 E7-expressing cells were exposed to UV radiation. After
five hours, the cells were collected and the number of Trypan blue-
negative (live) cells was counted. The differential survival rate
between cells that were unexposed and exposed to UV radiation
was determined and expressed as the percentage of dead cells after
UV exposure. The protective effect of the viral oncoprotein was
evident and statistically significant for the HaCaT cells, as
described [29,30], and for GSTP1-expressing MCF-7 cells, but
not for the GSTP1-deficient MCF-7 cells (Figure 7A).
To define the synergy between GSTP1 and HPV-16 E7 and the
role of their interaction in enhancing cell survival after UV
exposure, we used siRNA to down-regulate GSTP1 protein levels.
Control, HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT
cells were transfected with either control non-targeting (NT)
siRNA or siRNA targeting GSTP1. After 72 h, aliquots of the cells
Figure 3. Docking of HPV-16 E7 to GSTP1. A: Docking of the
GSTP1 monomer (from chain A of PDB entry 1AQW, represented as a
protein surface) and the HPV-16 E7 CR3 dimer (modeled in this study
and represented as a protein backbone with the two subunits
distinguished by green and orange colors). The portions of the GSTP1
surface that contribute the Cys 47 and Cys 101 residues are highlighted
in yellow. In the drawing, we have retained the structure of one
glutathione molecule co-crystallized with GSTP1 in the PDB entry 1AQW
to show its binding position (enzyme G-site). To show the enzymatic
region that binds substrates (H-site of GSTP1), we have included the
structure of the anticancer drug chlorambucil reproducing the same
binding position as in its co-crystal with GSTP1 (PDB structure 21GS). B:
In the docking model, the region of the GSTP1 monomer (surface
representation) that is in contact with the HPV-16 E7 CR3 dimer (orange
and green tube representation) is depicted in dark blue. C: The region
of contact between one GSTP1 subunit (surface representation) and the
other GSTP1 subunit (green tube representation) in the enzyme
homodimer (PDB entry 1AQW) is depicted in dark blue. In panels B
and C, regions of contact on the GSTP1 surfaces are identified as
residues located within 5 A ˚ of the ligand (HPV-16 E7 CR3 or the second
GSTP1 unit) and appear to partially overlap.
doi:10.1371/journal.pone.0007254.g003
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PLoS ONE | www.plosone.org 5 October 2009 | Volume 4 | Issue 10 | e7254Figure 4. Generation of HPV-16 E7 Mut and its in vitro interaction with GSTP1 and pRb. A. Legendas in Figure 3A. The red spheres shown on
oneHPV-16 E7subunit (greentube representation)highlightthealpha-carbonatomsofaminoacid residues49–60,whiletheblue spheres highlightthe
alpha-carbons of amino acid residues 88–98 (see Figure 2). The residues Val 55, Phe 57 and Met 84, mutated in HPV-16 E7 Mut, are highlighted by the
white clouds. B: In vitro interaction of radiolabeled IVT HPV-16 E7, but not of HPV-16 E7 Mut, with N-6His-GSTP1 recombinant protein. N-6His-RCC1
recombinant protein was used as a negative control. C: In vitro interaction of radiolabeled IVT HPV-16 E7 and HPV-16 E7 Mut with recombinant S.
japonicum GST-pRb protein. S. japonicum GST was used as a negative control. D: Western blot for GSTP1 after immunoprecipitation with an anti-HA
antibody (to precipitate tagged HPV-16 E7 and HPV-16 E7 Mut), in control, HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT cells shows a less efficient
co-precipitation of GSTP1 in HPV-16 E7 Mut-expressing cells; the same membrane was probed using an anti-HA antibody to assess the efficiency of the
immunoprecipitation procedure. Cell lysate was from HPV-16 E7-infected HaCaT cells. E: Reverse co-precipitation: Western blot for HA (to detect tagged
HPV-16 E7andHPV-16E7Mut)afterimmunoprecipitationwithananti-GSTP1antibodyincontrol,HPV-16E7- andHPV-16 E7Mut-expressingHaCaTcells
showsalessefficientco-precipitationofHPV-16E7MutwithGSTP1whencomparedtoHPV-16E7;thesamemembranewasprobedusingananti-GSTP1
antibody to assess the efficiency of the immunoprecipitation procedure. Cell lysate was from HPV-16 E7-infected HaCaT cells.
doi:10.1371/journal.pone.0007254.g004
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efficiency of siRNA-mediated silencing, which ranged from 75%
to 90%. The results of a representative experiment are shown in
the Western blot in Figure 7B. Cells were then aliquoted, exposed
to UV and processed as described above. In NT siRNA-
transfected HaCaT cells, HPV-16 E7 expression significantly
increased cell survival (Figure 7C, bars 1 and 3), confirming the
pro-survival role of the viral oncoprotein. However, this effect was
reduced considerably in GSTP1-silenced cells (Figure 7C, bars 2
and 4). In this setting, HPV-16 E7 Mut expression was only able to
partially protect HaCaT cells from death (Figure 7B, bars 1 and 5),
and this effect was drastically reduced in GSTP1-silenced cells
(Figure 7C, bars 5 and 6).
Discussion
In HaCaT cells expressing either wild-type or mutant HPV-16
E7, it is possible to trace oxidative events, which are highlighted by
Figure 5. GSTP1 activities in HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT cells. A: A representative Western blot for GSTP1 in control
cells and HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT cells. Blots were normalized against b-actin levels. B: GSTP1 enzymatic activity in control,
in HPV-16 E7- and HPV-16 E7 Mut-expressing HaCaT cells (see Materials and Methods). Values are averages of three different experiments6SEM and
their variations were not statistically significant. C: JNK protein levels in control and in HPV-16 E7- and in HPV-16 E7 Mut-expressing HaCaT cells that
were untreated or cells that were sampled after induction of oxidative stress by exposure to UV (UVB, 5 mJ/cm
2 for 1 min) with a 5 h recovery period,
evaluated using an antibody specific for the phosphorylated form of JNK (pJNK) and another antibody that detects total JNK levels (JNK, performed
on a separate twin gel). Only after UV exposure did HPV-16 E7-expressing cells display a markedly reduced JNK phosphorylation, while a lower
reduction in JNK phosphorylation was detectable in HPV-16 E7 Mut-expressing cells.
doi:10.1371/journal.pone.0007254.g005
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content and of SOD, catalase, and GSH-Px activities demon-
strates an active response from these cells to oxidative injuries.
These results are confirmed by those from other studies in HPV-
16 E7-transfected HaCaT cells [31] or HPV-16-infected kerati-
nocytes, where viral oncoproteins expression is associated with
increased resistance to UV radiation [32]. GSTP1 total protein
level and its catalytic activity in HaCaT cells were not influenced
by either the expression of HPV-16 E7 (a result in accord with
other laboratories) [33], or the expression of HPV-16 E7 Mut, a
mutant form of the oncoprotein engineered to reduce its binding
to GSTP1. In agreement with previous results [29], the changes
induced by expression of the viral oncoprotein appear associated
with enhanced HaCaT cell survival after UV exposure.
In this scenario, the direct link observed between the HPV-16
E7 viral factor and the GSTP1 protein confers a pivotal role to this
physical interaction in enacting the survival capabilities modulated
by GSTP1. GSTP1 acts as an intrinsic negative regulator of
apoptosis essentially through its inhibition of JNK signaling, and
we envision a mechanism by which GSTP1 is activated via
physical interaction with HPV-16 E7. Indeed, we have shown that
HPV-16 E7 strongly decreases the levels of oxidized GSTP1, thus
increasing the level of the reduced form, which interferes with
JNK signaling [11]. In addition, the concomitant up-regulation of
GSH levels in HPV-16 E7-infected cells might act synergistically
to increase the concentration of reduced GSTP1.
Multimerization of GSTP1 through intermolecular disulfide
formation, which occurs under oxidizing conditions, is associated
with enzyme inactivation. Cys 47 is the residue with the highest
reactivity towards thiol-specific reagents, and its covalent modifi-
cation is accompanied by a loss of GST activity [34]. GSTP1 is
also inactivated when Cys 47 forms an intramolecular disulfide
bond with Cys 101 [24]. On the basis of these observations, and as
suggested by our model in which HPV-16 E7 occupies the space
Figure 6. HPV-16 E7 influences the balance between oxidized and reduced GSTP1. A: Western blots for GSTP1 after non-reducing SDS-
PAGE in control and in HPV-16 E7-infected HaCaT cells under normal conditions (untreated) or after induction of oxidative stress by exposure to UV
(UVB, 5 mJ/cm
2 for 1 min) or hydrogen peroxide (0.5 mM H2O2 for 30 min). In the first case, detection was performed after a 90 min or 5 h recovery
period, while in the second case detection was performed after a 6 h period. In all cases, HPV-16 E7 expression was accompanied by a drastic
decrease in the GSTP1 oxidized multimeric form (GSTP1 multimerox) and of the lowest band, which represents the oxidized GSTP1 monomer (GSTP1
monomerox). GSTP1 monomerred denotes the reduced form. B: Western blots for GSTP1 after non-reducing SDS-PAGE in control, HPV-16 E7- and HPV-
16 E7 Mut-infected HaCaT cells after exposure to UV (UVB, 5 mJ/cm
2 for 1 min) and 5 h recovery. The mutant oncoprotein appeared less efficient in
protecting GSTP1 from oxidation. In both panels, blots were normalized against b-actin levels that were determined in matching gels run under
reducing conditions.
doi:10.1371/journal.pone.0007254.g006
Table 1. Modifications induced by HPV-16 E7 and HPV-16 E7 Mut expression on the redox equilibrium of HaCaT cells.
Parameter Control HPV-16 E7 HPV-16 E7 Mut
Lipid peroxidation TBARS (nmol/mg prot.) 0.3760.01 0.7160.04** 0.4260.09

PUFA (%) 25.3660.41 22.9260.91* 23.7660.83
Cytosol redox equilibrium SOD (U/mg prot.) 31.9162.05 38.2962.01* 37.9261.09*
Catalase (U/mg prot.) 6.3360.85 7.4561.01* 8.5260.93*
GSH-Px (mU/mg prot.) 0.5660.03 0.8560.03** 0.7460.02**/

GSH (nmol/mg prot.) 193.5362.74 235.67619.85* 240.00618.73*
Results are the averages6SD of three different determinations performed in duplicate. In the HPV-16 E7 column, asterisks indicate statistical significance between the
values reported for control and for HPV-16 E7-expressing cells (*=P,0.05; **=P,0.01). In the HPV-16 E7 Mut column, asterisks indicate statistical significance between
the values reported for control and for HPV-16 E7 Mut-expressing cells (*=P,0.05; **=P,0.01), while diamonds indicate statistical significance between the values
reported for HPV-16 E7 and HPV-16 E7 Mut-expressing cells (
=P,0.05;
=P,0.01).
doi:10.1371/journal.pone.0007254.t001
E7 and GSTP1 in Cell Survival
PLoS ONE | www.plosone.org 8 October 2009 | Volume 4 | Issue 10 | e7254between Cys 47 and Cys 101 of GSTP1 and prevents both
intramolecular and intermolecular disulfide formation, we propose
that HPV-16 E7 binding might protect GSTP1 against inactiva-
tion via oxidative attacks at Cys 47 and/or Cys 101. According to
our model, the binding of HPV-16 E7 to GSTP1 and GSTP1
homodimerization should be mutually exclusive, because these
two different complexes involve mostly overlapping regions of the
enzyme surface. Although we lack experimental evidence that
allows us to state whether GSTP1 retains GST activity when
bound by HPV-16 E7, it is remarkable how closely the
conformation of this complex emulates the pattern of intermolec-
ular contacts in the GSTP1 homodimer. We hypothesize that the
role of HPV-16 E7 is to establish a subset of GSTP1 molecules
that is inaccessible to oxidative attack, thus creating a reservoir of
reduced monomeric GSTP1. This hypothesis is strongly supported
by the results obtained from the expression in the HaCaT model
system of a HPV-16 E7 mutant that binds GSTP1 less efficiently.
Indeed, the mutant molecule we engineered, HPV-16 E7 Mut,
while unable to bind 6-His-GSTP1 in vitro as a recombinant
protein, displayed a certain residual effectiveness in vivo in binding
native GSTP1, in safeguarding it from oxidation and in protecting
the cells from UV-induced cell death. It is noteworthy that the
peculiar perturbation we generated in the HPV-16 E7 mutant
molecule by amino acid substitutions in the CR3 region did not
appreciably affect binding with pRb, which interacts with HPV-16
E7 mostly via the CR2 region, though involvement of the C-
terminal region has been reported [9,35].
The results we obtained in the GSTP1-deficient MCF-7 cell line
further support the active role of GSTP1 in HPV-16 E7-related
survival, where HPV-16 E7 expression did not protect MCF-7
cells from UV radiation-induced damage, unless GSTP1 was
forcibly co-expressed in this model system. The central role of
GSTP1 in mediating the pro-survival effects of HPV-16 E7
expression in HaCaT cells is also clearly outlined by the results
obtained from silencing GSTP1 expression via siRNA, while the
role of the physical interaction between these two factors is
indicated by the results generated from the expression of the
mutant form of the oncoprotein. Indeed, the survival of HPV-16
E7-expressing HaCaT cells after UV irradiation was significantly
decreased when GSTP1 protein levels were reduced by RNAi.
Notably, in this model system, the survival of control HaCaT cells
after UV exposure did not seem to rely on GSTP1 in the absence
of HPV-16 E7 expression. In addition, the results obtained in cells
expressing HPV-16 E7 Mut clearly highlighted the substantial role
of the physical interaction between the oncoprotein and GSTP1 in
modulating its anti-apoptotic, JNK-mediated activity.
These data underscore a clear role for HPV-16 E7 in enhancing
cell survival and provide additional evidence for the transforming
capabilities of the E7 oncoprotein from high-risk HPVs. Indeed,
HPV-16 E7 expression can a) accelerate or induce entry into the
cell cycle [8,9], b) induce mitotic abnormalities hence increasing
genomic instability [36,37], and c) increase cell survival, at least via
the pro-survival mechanisms discussed above. All of these
characteristics might act in concert to facilitate the rise and
selection of transformed cell clones and the progression of cancer
[38].
A closer examination of the molecular changes elicited by HPV
viral oncoproteins via their physical interaction with cellular
Figure 7. Roles of HPV-16 E7 and GSTP1 and their interaction
in cell survival after UV exposure. A: After exposure to UV radiation
(UVB, 5 mJ/cm
2 for 1 min), control and HPV-16 E7-expressing HaCaT
cells showed a significant correlation between HPV-16 E7 expression
and cell survival (p=0.000003, ***). Under the same conditions, GSTP1-
deficient MCF-7 cells displayed no significant differences in survival, and
thus no HPV-16 E7-related protection. Forced expression of GSTP1 in
control and HPV-16 E7-infected MCF-7 cells restored the ability of HPV-
16 E7 to protect against UV-induced cell death (p=0.0046, **). Values
are the averages of three independent experiments performed in
triplicate6SEM. B: Control, HPV-16 E7- and HPV-16 E7 Mut-infected
HaCaT cells were transfected with non-targeting (NT) siRNA or with
siRNA targeting GSTP1. After 72 h, GSTP1 siRNA-treated cells showed
decreased GSTP1 protein expression. C: Cells, exposed to UV radiation
as above, were collected and the number of Trypan blue-negative (live)
cells was determined. The differential survival rate between cells
unexposed and exposed to UV radiation was then calculated, and the
results were expressed as percentages of dead cells after UV exposure.
The results show a remarkable effect of HPV-16 E7 on cell survival (bars
1 vs. 3), a less effective protection by HPV-16 E7 Mut (bars 1 vs. 5), and
the consequences of GSTP1 silencing in HPV-16 E7- (bars 3 vs. 4) and
HPV-16 E7 Mut- expressing cells (bars 5 vs. 6). This panel indicates the
role of GSTP1 in HPV-16 E7-induced cell survival and the importance of
the binding ability of the oncoprotein in inducing the GSTP1-mediated
increase in survival. Values are the average of three independent
experiments performed in triplicate6SEM. Statistical significance of the
reported values: bars 1 vs. 3 p=0.00004, ***; bars 1 vs. 5 p=0.0009, ***;
bars 3 vs. 5 p=0.000004, ***; bars 3 vs. 4 p=0.0002, ***; bars 5 vs. 6
p=0.0001, ***; bars 2 vs. 4 p=0.0288, *; bars 4 vs. 6 p=0.0007, ***.
doi:10.1371/journal.pone.0007254.g007
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generated by these viruses during infection and transformation.
These findings will help in the development of unique molecular
tools that can prevent and treat virus-induced tumors.
Materials and Methods
Ethics Statement
Due to the fact that neither humans nor other animals have
been used in this research, an Ethics Statement is not required for
this work.
Plasmids, constructs and primers
Full-length HPV-16 E7 coding sequences were amplified by
PCR from HPV-16 cDNA template and cloned into the
pcDNA3T7 Tag plasmid and pLXSN retroviral vector in frame
with the N-terminal hemagglutinin (HA) epitope tag. Sequences of
oligonucleotide primers were as follows:
HPV-16 E7 forward oligonucleotide (FW). 59GATC-
GAATTCATGGCTTACCCATACGATGTTCCAGATTACG-
CTCATGGAGATACACCTACATTGCATG-39
HPV-16 E7 reverse oligonucleotide (RV).
59-GATCGGATCCGCAGGATCAGCCATGGTAGA-39
ORF encoding human GSTP1 was synthesized by RT-PCR
from HaCaT cells RNA using ‘‘First strand cDNA synthesis kit’’
(Amersham Biosciences, Piscataway, NJ) with the following
specific primers:
GSTP1 FW.
59GGGGACAAGTTTGTACAAAAAAGCAAGGCTTACC-
GCCCTACACCGTGGTCTATTTC-39
GSTP1 RV.
59GGGGACCACTTTGTACAAGAAAGCTGGGTCTCAC-
TGTTTCCCGTTGCCATTGATGGG-39
To facilitate GSTP1 cloning into the Gateway Entry vector
pDONR201 (Invitrogen, Carlsbad, CA), AttB1 and AttB2 tails
(indicated in boldface) were added to the 59 end of both FW and
RV primers.
Recombinant HPV-16 E7 and human pRb were expressed in
BL21 E. coli cells as S. japonicum GST fusions (pGEX-4T-1 and
pGEX-2T, respectively; Amersham Biosciences, Piscataway, NJ),
whereas human GSTP1 was expressed in BL21 E. coli cells as an
N-terminally 6His-tagged protein (pDEST17; Gateway cloning
system, Invitrogen). Proteins were purified by glutathione-
Sepharose 4B (Amersham Biosciences) (S. japonicum GST-tagged)
or on Ni-affinity (Qiagen, Milan, Italy) (N-6His-tagged) column
chromatography according to manufacturer’s instructions.
Recovery of specific bands and protein identification
Bands representing HaCaT cellular proteins specifically inter-
acting with GST-HPV-16 E7 were excised from the gel, incubated
for 20 min in the dark with destaining solutions provided in the
SilverQuest
TM Silver Staining kit (Invitrogen), and subjected to
tryptic proteolysis, using the In-gel Digest kit (Millipore Corpo-
ration, Billerica, MA) as described [39]. The mass spectrometry
analyses were performed with a MALDI-ToF Voyager-DE STR
instrument (Applied Biosystems, Framingham, MA), equipped
with a 337 nm nitrogen laser and operating in reflector mode. All
mass spectra were internally calibrated with two tryptic autolytic
peptides (m/z 842.5100 and 2807.3145). The mass lists obtained
from each PMF analyzed, after exclusion of the contaminant mass
values (autolytic tryptic peptides and tryptic human keratin
fragments) by the PeakErazor program (http://www.protein.sdu.
dk/gpmaw/Help/PeakErazor/peakerazor.html), were used to
search for protein candidates in (human) NCBLnr database
consulting the Mascot search engine (http://www.matrixscience.
com). All searches respected the following parameters: one missed
cleavage, 50 ppm measurement tolerance, oxidation at methio-
nine (as variable modification). Positive identifications were
accepted when, with at least five peptide masses matched, P
values (the probability that the observed match is a random event)
were lower than 0.05.
Site-directed mutagenesis
Mutations were introduced into the HPV-16 E7 plasmid
construct using the QuickChange Site-Directed Mutagenesis kit
(Stratagene, La Jolla, CA) according to the manufacturer’s
instructions. To obtain triple point mutation, the following
mutagenesis primer pairs were used to perform two consecutive
rounds of PCR amplification cycles in the HPV-16 E7 cDNA
construct plasmid:
Double mutation (V55A–F 57A). FW: 59-CCCATTACAA-
TATTGCAACCGCTTGTTGCAAGTGTGACTCTACGC-39
RV: 59-GCGTAGAGTCACACTTGCAACAAGCGGTTG-
CAATATTGTAATGGG-39
Single mutation (M84A). FW: 59-CCGTACGTTGGAA-
GACCTGTTAGCAGGCACACTAGGAATTGTGTG-39
RV: 59-CACACAATTCCTAGTGTGCCTGCTAACAGGT-
CTTCCAACGTACGG-39
For all primers, mutagenized positions are underlined.
PCR amplifications were performed under the following
conditions: denaturation at 95uC for 2 min, followed by 12 cycles
of denaturation at 95uC for 30 s, annealing at 55uC for 50 s and
extension at 68uC for 5 min.
Destruction of the methylated, parental DNA plasmid by DpnI
digestion followed by E.coli cells transformation allowed the
introduction of the desired mutations. The mutation site and the
fidelity of HPV-16 E7 coding sequence were confirmed by DNA
sequencing.
Cell lines
The cell lines used were cultured in DMEM (Invitrogen) plus
10% fetal bovine serum (Invitrogen) at 37uC in a 5% CO2
atmosphere. HaCaT cells were cultured at low density (max.
40% confluent), and CaSki cells using DMEM+GlutaMAX-I
(Invitrogen).
Incubation of recombinant HPV-16 E7 with cell lysate and
SDS-PAGE analysis
HaCaT cells were lysed in 50 mM Tris-Cl, pH 7.4 with 5 mM
EDTA, 250 mM NaCl, and 0.1% Triton X-100 (lysis buffer) plus
protease inhibitors (1 mM PMSF, 10 mg/ml aprotinin and
leupeptin) for 30–40 min on ice. Chimeric GST-HPV-16 E7
protein (1.5 mg) was added to the lysate and incubated for 100 min
at 4uC. Recombinant proteins, and any bound molecules were
collected by adding insoluble glutathione-Sepharose 4B (Amer-
sham Biosciences). Precipitated complexes were analyzed by 10%
SDS-PAGE, followed by silver staining (Bio-Rad Laboratories,
Hercules, CA).
PepSets
TM technology
To precisely identify the amino acids involved in the interaction
between HPV-16 E7 and GSTP1, we employed PepSets
TM
technology (Mimotopes Pty Ltd, Clayton, Victoria, Australia), as
described [30,40,41]. The reactivity of these rod-bound peptides
was then assayed for their ability to physically interact with
recombinant GSTP1. The amount of protein captured by each
rod was detected via a modified immunoenzyme assay using an
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at a 1:2,000 dilution. At the end of the procedure, plates were
analyzed in a microtiter reader.
Modeling of the docking of HPV-16 E7 to GSTP1
The interaction between HPV-16 E7 and GSTP1 has been
assumed to involve the dimeric and monomeric forms of the two
proteins, respectively. The dimer of the CR3 domain of HPV-16
E7 in the amino acid interval 48 to 98 was modeled with the
program MODELLER release 8v2 [42] using the structure of
the dimer of the homologous CR3 domain of HPV-1A E7 (PDB
code 2B9D) as a template. The GSTP1 monomer was represented
by chain A of the PDB structure 1AQW, with the assumption that
it does not undergo conformational changes in the absence of
crystallographically bound molecules (the second bound monomer
in the GSTP1 homodimer, glutathione and salts). Docking of the
HPV-16 E7 dimer with the GSTP1 monomer was performed
using the program Hex v4.5 (Department of Computing Science,
University of Aberdeen, Aberdeen AB24 3UE, Scotland, UK;
http://www.csd.abdn.ac.uk/hex/), allowing full translational and
rotational searching and recording the 500 best score solutions.
In vitro binding assay
For the experiment shown in Figure 1B, in vitro translation of
HPV-16 E7 was performed as described [18], using
35S-
methionine as a radioactive label. For the experiments shown in
Figure 1G, in vitro translation of HPV-33 E7 and of HPV-18 E7,
and in Figure 4, in vitro translation of HPV-16 E7 and HPV-16 E7
Mut, assays were performed using
35S-cysteine as a radioactive
label. Aliquots of reaction mixtures containing in vitro-translated
proteins were added to Ni-NTA agarose beads coupled to 4 mgo f
recombinant N-6His RCC1 (negative control) or recombinant N-
6His GSTP1. Alternatively, aliquots of reaction mixtures contain-
ing the in vitro-translated proteins were added to glutathione-
Sepharose 4B coupled to 1 mgo fS. japonicum GST-pRb or S.
japonicum GST (negative control). Incubation, 12% SDS-PAGE,
and detection were performed as described [18].
GST activity
GST catalytic activity was assayed using 1-chloro-2,4-dinitro-
benzene (CDNB) as an electrophilic substrate (Sigma) in the
presence or absence of 4 mM ethacrynic acid (EA), an inhibitor of
GSTP1 activity [43], to quantify the contribution of GSTP1
activity to overall cellular GST enzyme activity. Conjugation of
the thiol group of glutathione to the CDNB substrate was
monitored by recording changes in absorbance at 340 nm
between 0.5 and 6 min after initiating the reaction at 22uC.
GST catalytic activity was expressed as nmol of CDNB/min/mgo f
protein. Results are averages6SEM of three different determina-
tions performed in duplicate.
Transfections and infections
Calcium phosphate transfection of Phoenix cells with
pcDNA3T7 Tag and pcDNA3T7 Tag HPV-16 E7 plasmids were
performed using standard procedures. Transfection of pDEST26
or pDEST26-GSTP1 in control- and HPV-16 E7-infected MCF-7
cells was done by electroporation using the Gene Pulser II
apparatus (Bio-Rad) according to Manufacturer’s instructions.
For the infection procedure, Phoenix amphotropic packaging
cells were transfected with HA-tagged pLXSN (Clontech),
pLXSN-HPV-16-E7 or pLXSN-HPV-16-E7 Mut as described
[30]. HaCaT or MCF-7 infection by Phoenix cell supernatants
and clone selection were carried out as described [30].
In vivo co-immunoprecipitations
Phoenix or HaCaT cells were lysed in lysis buffer (50 mM Tris-
Cl, pH 7.4, 5 mM EDTA, 250 mM NaCl, 50 mM NaF, 0.1%
Triton X-100, 0.1 mM Na3VO4, 1 mM PMSF, 10 mg/ml
Leupeptin) for 30 min on ice. Lysates were centrifuged at
14,0006g for 10 min at 4uC. Lysates were cleared and incubated
with one of the following antibodies: anti-T7 Tag, monoclonal,
(Novagen, Madison, WI, 1:100 dilution); anti-HPV-16 E7,
monoclonal, (ed-17, Santa Cruz Biotechnology, Santa Cruz, CA,
1 ml:100 mg lysate); anti-GSTP1, polyclonal (Assay Designs, Ann
Arbor, MI.; 1:100 v:v dilution) for 2 h, followed by incubation
with protein A-Sepharose (for anti-T7 Tag and anti-HPV-16 E7
primary Abs) or G-Sepharose (for anti-GSTP1 primary antibody)
beads in lysis buffer. The beads were subjected to four rounds of
washing with 1 ml of lysis buffer, then immunoprecipitates were
eluted by adding electrophoresis sample buffer. Proteins were
resolved through SDS-PAGE, transferred to PVDF membranes
and probed with the specific antibodies indicated in the Western
blotting section.
Western blot analysis
SDS-PAGE and Western blot analysis were performed as
described [18]. Where indicated, proteins were separated under
non-reducing conditions in SDS-PAGE by excluding b-mercap-
toethanol from the sample buffer. Membranes were probed with
primary antibodies followed by horseradish peroxidase-conjugated
anti-rabbit or anti-mouse immunoglobulins. Immunoreactive
bands were detected using ECL reagents (Amersham Biosciences).
The following antibodies and dilutions were used: anti-SAPK/
JNK pAb (Cell Signaling, Beverly, MA, 1:1,000 dilution) against
total JNK; anti-phospho-SAPK/JNK (Thr183/Tyr 185) pAb (Cell
Signaling, 1:1,000 dilution) against phosphorylated forms of JNK;
anti-HA-tag mAb (Cell Signaling, 1:1,000 dilution) against
influence hemagglutinin epitope; anti-GSTP1-1 pAb (Assay
Designs, Ann Arbor, MI.; 1:10,000 dilution); anti-b actin mAb
(MP Biomedicals, Irvine, CA., 1:10,000 dilution).
Analysis of the cellular redox equilibrium
Thiobarbituric acid reactive substances (TBARS)
analysis. Evaluation of TBARS was performed as described
[44]. Standard curves were obtained using malondialdehyde
(MDA) standard solutions at different concentrations (1.25, 0.5,
0.25 and 0.1 mM). TBARS values were expressed as nmol/mg of
protein.
Poly-unsaturated fatty acids (PUFAs) analysis. Eval-
uation of PUFAs in the phospholipid fraction of cell membranes
was performed as described [45]. Results were expressed as
percent variations.
Antioxidant enzymatic activities. Antioxidant enzymatic
activities were determined in the supernatants of native cell lysates
obtained after repeated freezing and thawing in liquid nitrogen
and subsequent centrifugation at 10,000 g for 10 min at 4uC.
The activities of superoxide dismutase (SOD) [46], catalase [47]
and glutathione peroxidase (GSH-Px) [48] were determined
spectrophotometrically as described and expressed as U/mg of
protein for SOD and catalase and as mU/mg of protein for
GSH-Px.
GSH determination. GSH cellular content was estimated as
described [49]. Results were expressed as nmol/mg of protein.
siRNA transfection
For gene silencing experiments, HaCaT cells were plated at a
density of 1610
5 cells in 35-mm dishes 24 h before transfection.
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of transfection) was critical for transfection efficiency.
On-Target siRNA (SMARTpool L-011179, Dharmacon, Inc.
Lafayette, CO) or On-Target plus siControl (Non-targeting pool, D-
001810-10 Dharmacon) were transfected (50 nM for 5 h) using
Lipofectamine 2000 (Invitrogen) (10 ml per dish) according to the
manufacturer’s instructions. siCONTROL TOX Non Targeting
siRNA (D-001500-01 Dharmacon) was used as an indicator of
transfection efficiency. GSTP1 protein levels were assessed by
Western blot 72 h post-transfection.
Cell viability assays
Viability was measured by the ability of cells to exclude Trypan
blue dye (Invitrogen). Trypsinized cells were incubated with 0.4%
Trypan blue and examined microscopically. The percentage of
cells that excluded Trypan blue was determined by counting 100
cells in triplicate per experimental condition in a hemocytometer.
The differential survival rate between cells unexposed and exposed
to UV radiation was determined and expressed as percentage of
dead cells after UV exposure.
Statistical analysis
Statistical analysis of the results was performed using the two-
tailed Student’s t test, with GraphPad Prism v5.01 for Windows
(GraphPad Software, San Diego CA).
Supporting Information
Materials and Methods S1
Found at: doi:10.1371/journal.pone.0007254.s001 (0.03 MB
DOC)
Figure S1 HPV-16 E7 and HPV-16 E7 Mut protein expression
in HaCaT cells. Western blot detection of the wild-type and
mutant viral oncoproteins (anti-HA Ab) in HPV-16 E7- and in
HPV-16 E7 Mut-infected HaCaT cells; control cells resulted
negative. The blot was normalized against b-actin levels.
Found at: doi:10.1371/journal.pone.0007254.s002 (0.29 MB TIF)
Figure S2 HPV-16 E7 and GSTP1 protein expression in
HaCaT and in GSTP1-deficient and in GSTP1-tranfected
MCF7 cells. A: Western blot for HPV-16 E7 (anti-HA Ab) and
GSTP1 in control and HPV-16 E7-infected HaCaT and MCF-7
cells, showing the expression of the viral oncoprotein in both
infected cell clones and GSTP1 undetectability in the MCF-7 cells.
The blot was normalized against b-actin levels. B. Western blot for
HPV-16 E7 (anti-HA Ab) and GSTP1 in control and HPV-16 E7-
infected HaCaT and in GSTP1-transfected MCF-7 cells, showing
the expression of the viral oncoprotein in both infected cell clones
and of GSTP1 in the transfected MCF-7 cells. The blot was
normalized against b-actin levels.
Found at: doi:10.1371/journal.pone.0007254.s003 (0.69 MB TIF)
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